1.1 Articolo in rivista

1.1 Articolo in rivista: [37665] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 11.481 a 11.500 di 37.665

Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case-Matched Control Study

2017-01-01 Gallotta, V.; Cicero, C.; Conte, C.; Vizzielli, G.; Petrillo, M.; Fagotti, A.; Chiantera, V.; Costantini, B.; Scambia, G.; Ferrandina, G.

Epithelial ovarian cancer relapsing as isolated lymph node disease: Natural history and clinical outcome

2008-01-01 Legge, F.; Petrillo, M.; Adamo, V.; Pisconti, S.; Scambia, G.; Ferrandina, G.

A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge

2007-01-01 Ferrandina, G.; Legge, F.; Mey, V.; Nannizzi, S.; Ricciardi, S.; Petrillo, M.; Corrado, G.; Scambia, G.

Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience

2014-01-01 Vizzielli, G.; Costantini, B.; Tortorella, L.; Petrillo, M.; Fanfani, F.; Chiantera, V.; Ercoli, A.; Iodice, R.; Scambia, G.; Fagotti, A.

Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis

2014-01-01 Petrillo, M.; Pedone Anchora, L.; Tortorella, L.; Fanfani, F.; Gallotta, V.; Pacciani, M.; Scambia, G.; Fagotti, A.

The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer

2017-01-01 Leonardi, S.; Buttarelli, M.; De Stefano, I.; Ferrandina, G.; Petrillo, M.; Babini, G.; Scambia, G.; Marino, C.; Mancuso, M.; Gallo, D.

A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer

2019-01-01 Buttarelli, M.; Babini, G.; Raspaglio, G.; Filippetti, F.; Battaglia, A.; Ciucci, A.; Ferrandina, G.; Petrillo, M.; Marino, C.; Mancuso, M.; Saran, A.; Villani, M. E.; Desiderio, A.; D'Ambrosio, C.; Scaloni, A.; Scambia, G.; Gallo, D.

Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery

2010-01-01 Ferrandina, G.; Margariti, P. A.; Smaniotto, D.; Petrillo, M.; Salerno, M. G.; Fagotti, A.; Macchia, G.; Morganti, A. G.; Cellini, N.; Scambia, G.

Feasibility and safety of laparoscopic approach in obese patients with endometriosis: a multivariable regression analysis

2020-01-01 Raimondo, D.; Raimondo, I.; Degli Esposti, E.; Mattioli, G.; Mastronardi, M.; Petrillo, M.; Dessole, S.; Mabrouk, M.; Del Forno, S.; Arena, A.; Borghese, G.; Seracchioli, R.

Incidence and predictive factors for complications after uterine leiomyoma embolization

2014-01-01 Tropeano, G.; Amoroso, S.; Di Stasi, C.; Di Bidino, R.; Monterisi, A.; Petrillo, M.; Scambia, G.

FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases

2016-01-01 Zannoni, G. F.; Improta, G.; Petrillo, M.; Pettinato, A.; Scambia, G.; Fraggetta, F.

Minimally Invasive Secondary Cytoreduction Plus HIPEC Versus Open Surgery Plus HIPEC in Isolated Relapse From Ovarian Cancer: A Retrospective Cohort Study on Perioperative Outcomes

2015-01-01 Fagotti, A.; Costantini, B.; Gallotta, V.; Cianci, S.; Ronsini, C.; Petrillo, M.; Pacciani, M.; Scambia, G.; Fanfani, F.

Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

2016-01-01 Petrillo, M.; De Iaco, P.; Cianci, S.; Perrone, M.; Costantini, B.; Ronsini, C.; Scambia, G.; Fagotti, A.

Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study

2014-01-01 Ferrandina, G.; Petrillo, M.; Mantegna, G.; Fuoco, G.; Terzano, S.; Venditti, L.; Marcellusi, A.; De Vincenzo, R.; Scambia, G.

Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation?

2008-01-01 Ferrandina, G.; Fanfani, F.; Ludovisi, M.; Fagotti, A.; Carbone, A.; Zannoni, G.; Guerriero, M.; Petrillo, M.; Scambia, G.

Novel targets for VEGF-independent anti-angiogenic drugs

2012-01-01 Petrillo, M.; Scambia, G.; Ferrandina, G.

BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study

2017-01-01 Petrillo, M.; Marchetti, C.; De Leo, R.; Musella, A.; Capoluongo, E.; Paris, I.; Benedetti Panici, P.; Scambia, G.; Fagotti, A.

Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts

2017-01-01 Todeschini, P.; Salviato, E.; Paracchini, L.; Ferracin, M.; Petrillo, M.; Zanotti, L.; Tognon, G.; Gambino, A.; Calura, E.; Caratti, G.; Martini, P.; Beltrame, L.; Maragoni, L.; Gallo, D.; Odicino, F. E.; Sartori, E.; Scambia, G.; Negrini, M.; Ravaggi, A.; D'Incalci, M.; Marchini, S.; Bignotti, E.; Romualdi, C.

Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience

2020-01-01 Sozzi, G.; Petrillo, M.; Berretta, R.; Capozzi, V. A.; Paci, G.; Musico, G.; Di Donna, M. C.; Vargiu, V.; Bernardini, F.; Lago, V.; Domingo, S.; Fagotti, A.; Scambia, G.; Chiantera, V.

Challenges in Gynecological Cancer: Biology, Diagnosis, Surgical, and Medical Treatment

2015-01-01 Zapardiel, I.; Rajaram, S.; Piovano, E.; Petrillo, M.

Titolo	Data di pubblicazione	Autore(i)
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case-Matched Control Study	1-gen-2017	Gallotta, V.; Cicero, C.; Conte, C.; Vizzielli, G.; Petrillo, M.; Fagotti, A.; Chiantera, V.; Costantini, B.; Scambia, G.; Ferrandina, G.
Epithelial ovarian cancer relapsing as isolated lymph node disease: Natural history and clinical outcome	1-gen-2008	Legge, F.; Petrillo, M.; Adamo, V.; Pisconti, S.; Scambia, G.; Ferrandina, G.
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge	1-gen-2007	Ferrandina, G.; Legge, F.; Mey, V.; Nannizzi, S.; Ricciardi, S.; Petrillo, M.; Corrado, G.; Scambia, G.
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience	1-gen-2014	Vizzielli, G.; Costantini, B.; Tortorella, L.; Petrillo, M.; Fanfani, F.; Chiantera, V.; Ercoli, A.; Iodice, R.; Scambia, G.; Fagotti, A.
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis	1-gen-2014	Petrillo, M.; Pedone Anchora, L.; Tortorella, L.; Fanfani, F.; Gallotta, V.; Pacciani, M.; Scambia, G.; Fagotti, A.
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer	1-gen-2017	Leonardi, S.; Buttarelli, M.; De Stefano, I.; Ferrandina, G.; Petrillo, M.; Babini, G.; Scambia, G.; Marino, C.; Mancuso, M.; Gallo, D.
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer	1-gen-2019	Buttarelli, M.; Babini, G.; Raspaglio, G.; Filippetti, F.; Battaglia, A.; Ciucci, A.; Ferrandina, G.; Petrillo, M.; Marino, C.; Mancuso, M.; Saran, A.; Villani, M. E.; Desiderio, A.; D'Ambrosio, C.; Scaloni, A.; Scambia, G.; Gallo, D.
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery	1-gen-2010	Ferrandina, G.; Margariti, P. A.; Smaniotto, D.; Petrillo, M.; Salerno, M. G.; Fagotti, A.; Macchia, G.; Morganti, A. G.; Cellini, N.; Scambia, G.
Feasibility and safety of laparoscopic approach in obese patients with endometriosis: a multivariable regression analysis	1-gen-2020	Raimondo, D.; Raimondo, I.; Degli Esposti, E.; Mattioli, G.; Mastronardi, M.; Petrillo, M.; Dessole, S.; Mabrouk, M.; Del Forno, S.; Arena, A.; Borghese, G.; Seracchioli, R.
Incidence and predictive factors for complications after uterine leiomyoma embolization	1-gen-2014	Tropeano, G.; Amoroso, S.; Di Stasi, C.; Di Bidino, R.; Monterisi, A.; Petrillo, M.; Scambia, G.
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases	1-gen-2016	Zannoni, G. F.; Improta, G.; Petrillo, M.; Pettinato, A.; Scambia, G.; Fraggetta, F.
Minimally Invasive Secondary Cytoreduction Plus HIPEC Versus Open Surgery Plus HIPEC in Isolated Relapse From Ovarian Cancer: A Retrospective Cohort Study on Perioperative Outcomes	1-gen-2015	Fagotti, A.; Costantini, B.; Gallotta, V.; Cianci, S.; Ronsini, C.; Petrillo, M.; Pacciani, M.; Scambia, G.; Fanfani, F.
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC)	1-gen-2016	Petrillo, M.; De Iaco, P.; Cianci, S.; Perrone, M.; Costantini, B.; Ronsini, C.; Scambia, G.; Fagotti, A.
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study	1-gen-2014	Ferrandina, G.; Petrillo, M.; Mantegna, G.; Fuoco, G.; Terzano, S.; Venditti, L.; Marcellusi, A.; De Vincenzo, R.; Scambia, G.
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation?	1-gen-2008	Ferrandina, G.; Fanfani, F.; Ludovisi, M.; Fagotti, A.; Carbone, A.; Zannoni, G.; Guerriero, M.; Petrillo, M.; Scambia, G.
Novel targets for VEGF-independent anti-angiogenic drugs	1-gen-2012	Petrillo, M.; Scambia, G.; Ferrandina, G.
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study	1-gen-2017	Petrillo, M.; Marchetti, C.; De Leo, R.; Musella, A.; Capoluongo, E.; Paris, I.; Benedetti Panici, P.; Scambia, G.; Fagotti, A.
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts	1-gen-2017	Todeschini, P.; Salviato, E.; Paracchini, L.; Ferracin, M.; Petrillo, M.; Zanotti, L.; Tognon, G.; Gambino, A.; Calura, E.; Caratti, G.; Martini, P.; Beltrame, L.; Maragoni, L.; Gallo, D.; Odicino, F. E.; Sartori, E.; Scambia, G.; Negrini, M.; Ravaggi, A.; D'Incalci, M.; Marchini, S.; Bignotti, E.; Romualdi, C.
Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience	1-gen-2020	Sozzi, G.; Petrillo, M.; Berretta, R.; Capozzi, V. A.; Paci, G.; Musico, G.; Di Donna, M. C.; Vargiu, V.; Bernardini, F.; Lago, V.; Domingo, S.; Fagotti, A.; Scambia, G.; Chiantera, V.
Challenges in Gynecological Cancer: Biology, Diagnosis, Surgical, and Medical Treatment	1-gen-2015	Zapardiel, I.; Rajaram, S.; Piovano, E.; Petrillo, M.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 11.481 a 11.500 di 37.665

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext33551
open3617
reserved293
restricted136
partially open66
mixed2